BioNTech SE (BNTX) Change in Intangibles (2024 - 2025)

BioNTech SE (BNTX) reported Change in Intangibles of $1.3 million for Q4 2025, up 104.89% on a YoY basis from $624941.5 in Q4 2024, and up 140.57% sequentially from -$3.2 million in Q3 2025.

BioNTech SE (BNTX) Change in Intangibles (2024 - 2025) Analysis & Trends

BioNTech SE (BNTX) has 2 years of Change in Intangibles data on file, last reported at $1.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Intangibles rose 104.89% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at -$672.4 million (changed N/A YoY), and the FY2025 full-year result was -$648.4 million, down 265.97% from the prior year.
  • Change in Intangibles climbed to $1.3 million in Q4 2025, from -$3.2 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $1.3 million in Q4 2025 to a low of -$644.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 BioNTech SE 21.56 Bn 21.56 Bn 668.28 Mn 1.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.28 Mn
Dec 31, 2025 1.28 Mn
Sep 30, 2025 -3.16 Mn
Sep 30, 2025 -3.16 Mn
Jun 30, 2025 -644.31 Mn
Jun 30, 2025 -644.31 Mn
Dec 31, 2024 -26.18 Mn
Dec 31, 2024 -26.18 Mn
Sep 30, 2024 -11.20 Mn
Sep 30, 2024 -11.20 Mn
Jun 30, 2024 -84.43 Mn
Jun 30, 2024 -84.43 Mn